COVID-19 Health Evidence Summary No.61 by Millington, Kerry & Reddin, Samantha
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.61 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
12 June 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 11.06.2020 Merits and 
culprits of 
immunotherapies 
for neurological 
diseases in times 
of COVID-19 
EBioMedicine 
| Review 
 An overview, of 
the most recently 
available data 
about SARS-CoV-
2 and the 
approved 
immunotherapies 
for neurological 
diseases, that 
includes current 
treatment 
strategies and the 
associated 
COVID-19 risk 
and the potential 
of 
immunotherapies 
to treat COVID-19 
 Immunotherapy, 
neurology 
  
2 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
12.06.2020 Predicted 
COVID-19 
fatality rates 
based on 
age, sex, 
comorbidities, 
and health 
system 
capacity 
CGD | 
Working 
Paper 
 Non-random testing and 
incomplete vital registration 
systems challenge 
estimating directly the 
infection fatality rate (IFR) 
in many LMICs 
 This paper estimates the 
adjustments required to 
extrapolate estimates of 
IFR from high- to lower-
income regions 
 Predicted IFR across 21 
world regions range from 
0.11% in Western sub-
Saharan Africa to 1.07% 
for high-income Asia 
Pacific when accounting 
for differences in the 
distribution of age, sex, 
and relevant comorbidities 
 Adjusting for health system 
capacity greatly 
diminishes, but does not 
erase entirely, the 
demography-based 
advantage predicted from 
the lowest income settings 
 Code for this paper is 
available 
Mortality, 
LMICs 
 12.06.2020 The 
effectiveness 
of social 
bubbles as 
part of a 
Covid-19 
lockdown exit 
strategy, a 
modelling 
study 
 medRxiv | 
Preprint (not 
peer 
reviewed) 
 The impact of contact 
clustering in social 
bubbles, as part of gradual 
lockdown exit strategy, on 
epidemic and mortality risk 
was estimated using the 
UK as a case study 
 Analysis highlights the 
continued need for social 
distancing despite a social 
bubble strategy being 
effective in expanding 
contacts while limited the 
risk for a resurgence of 
cases.  
 Recommending social 
bubbles only for those 
struggling with lockdown 
alongside continuing 
prioritising outdoor settings 
Social 
bubbles, 
exit 
strategy 
3 
for gathers and maintaining 
social distancing could 
strike a balance between 
minimising the impact on 
mental health and 
minimising the C19 
epidemic risk 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
12.06.2020 The impact 
of COVID-
19 and 
strategies 
for 
mitigation 
and 
suppression 
in low- and 
middle-
income 
countries 
Science | 
Research 
Article 
 Analysis combines data 
on demography, contact 
patterns, disease severity 
and health care capacity 
and quality to understand 
its impact and inform 
strategies for its control 
 Limited health system 
capacity and closer inter-
generational contact 
negate the “benefit” of 
younger populations in 
LICs 
 Mitigation strategies that 
slow but do not interrupt 
transmission will still 
result in health systems 
being overwhelmed due 
to the poorer health care 
available 
 Many lower income 
countries acted quickly 
when transmission was 
low which likely 
substantially slowed viral 
spread 
 This will need to be 
maintained or triggered 
frequently to keep within 
health care capacity 
Mitigation, 
suppression, 
health care 
capacity 
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Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
11.06.2020 Systematic 
SARS-CoV-2 
screening in 
cerebrospinal 
fluid during 
the COVID-
19 pandemic 
The Lancet 
Microbe | 
Correspondence 
 Retrospective systematic 
screening of all 
cerebrospinal fluid (CSF) 
samples (n=622) at 
University Hospital in Lyon, 
France 1 Feb to 11 May 
2020 
 SARS-CoV-2 detection in 
CSF samples was very low 
suggesting that although 
SARS-CoV-2 can replicate 
in neuronal cells in vitro, 
SARS-CoV-2 testing in 
CSF is currently not 
relevant in the general 
population 
 Further studies are required 
to identify the potential role 
of the host-immune 
response on neurological 
manifestation in patients 
with C19 
Testing, 
CSF  
12.06.2020 Evaluation of 
sample 
pooling for 
screening of 
SARS-CoV-2 
medRxiv | 
Preprint (not 
peer reviewed) 
 This study recommends 
pooling of 4 in 1 using the 
standard protocols of the 
assay, reagents and 
equipment, expected to 
retain test accuracy 
 This approach allows 
expansion of screening 
capacity  
 Sample 
pooling 
12.06.2020 An imperfect 
tool: COVID-
19 ‘test & 
trace’ 
success 
relies on 
minimising 
the impact of 
false 
negatives 
and 
continuation 
of physical 
distancing 
 medRxiv | 
Preprint (not 
peer reviewed) 
 Although this study extends 
an existing UK-focused 
branching process model, it 
highlights that test accuracy 
must be considered when 
relaxing physical distancing 
measures through contact 
tracing. 
Test 
accuracy 
5 
Therapeutics 
Publicatio
n date 
Title/URL Journal/Articl
e type 
Summary             Keywords 
11.06.2020 Hydroxychloroquin
e proves ineffective 
in hamsters and 
macaques infected 
with SARS-CoV-2 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
 Although many human 
clinicals trials are 
ongoing assessing 
efficacy of 
prophylactic/therapeuti
c use of 
hydroxychloroquine 
(HCQ) for C19 there 
remains a lack of 
supportive preclinical 
drug efficacy studies 
 This preclinical animal 
study in two animal 
models does not 
support the use of 
HCQ in 
prophylaxis/treatment 
of C19 
 Preclinical
, HCQ 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
13.06.2020 COVID-19 vaccines for all?  The Lancet | World 
Report 
Ann Danaiya 
Usher 
13.06.2020 Offline: COVID-19 - what can we expect 
to come 
The Lancet | 
Comment 
Richard Horton 
12.06.2020 Predicting COVID-19 infection fatality 
rates around the world 
CGD | Blog Justin Sandefur 
et al. 
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Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
 10.06.2020 COVID-19 
measures must be 
grounded first and 
foremost on the 
right to health 
OHCHR | 
Press 
release 
 UN Human Rights Special 
Rapporteur press release on the 
right to health foundation of the 
C19 response 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
COVID-
evidence 
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C19 Policy 
responses 
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
  
8 
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
9 
COVID-19 
Digest 
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
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Sustainable 
Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
          
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
11 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
12 
coronavirus disease 
outbreak 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
